Cellular labeling for nuclear magnetic resonance techniques

The disclosure provides, in part, fluorocarbon imaging reagents and formulations for the ex vivo labeling of cells. Labeled cells may be detected in vivo or ex vivo by a nuclear magnetic resonance technique, such as magnetic resonance imaging (MRI) or magnetic resonance spectroscopy (MRS). The disclosure additionally provides methods for using the imaging reagents in a variety of clinical procedures.

Attached files:
EP 2319544.jpg

EP 2,319,544

Inventor(s): AHRENS ERIC T [US]

Type of Offer: Licensing

Next Patent »
« More Biomedical Patents

Share on      

CrowdSell Your Patent